The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
BANK OF AMERICA CORPORATIONCOM06050510422614,532SH SOLE 14,53200
COMCAST CORP NEWCL A20030n10180815,547SH SOLE 15,54700
COMCAST CORP NEWCL A SPL20030n20091,3061,830,521SH SOLE 1,830,52100
EXPRESS SCRIPTS HLDG COCOM30219g108278,0373,958,387SH SOLE 3,958,38700
HALLIBURTON COCOM406216101240,9364,747,513SH SOLE 4,747,51300
HIGHER ONE HLDGS INCCOM42983d10422,3942,294,480SH SOLE 2,294,48000
KINDER MORGAN MANAGEMENT LLCSHS49455u100137,8881,822,469SH SOLE 1,822,46900
MICROSOFT CORPCOM594918104148,1773,960,893SH SOLE 3,960,89300
ORACLE CORPCOM68389x105270,5227,070,613SH SOLE 7,070,61300
PRIMERICA INCCOM74164m108145,4553,389,761SH SOLE 3,389,76100
SCHWAB CHARLES CORP NEWCOM808513105206,8117,954,268SH SOLE 7,954,26800
TIDEWATER INCCOM8864231021,16319,625SH SOLE 19,62500
VALEANT PHARMACEUTICALS INTLCOM91911k102717,6936,113,227SH SOLE 6,113,22700
VISTAPRINT N VSHSn93540107181,3123,189,305SH SOLE 3,189,30500